- Home
- LXRX vs GMRE Comparison
LXRX vs GMRE Comparison
Compare LXRX & GMRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LXRX
- GMRE
- Stock Information
- Founded
- LXRX 1995
- GMRE 2011
- Country
- LXRX United States
- GMRE United States
- Employees
- LXRX N/A
- GMRE N/A
- Industry
- LXRX Biotechnology: Pharmaceutical Preparations
- GMRE Real Estate Investment Trusts
- Sector
- LXRX Health Care
- GMRE Real Estate
- Exchange
- LXRX Nasdaq
- GMRE Nasdaq
- Market Cap
- LXRX 428.8M
- GMRE 508.9M
- IPO Year
- LXRX 2000
- GMRE N/A
- Fundamental
- Price
- LXRX $1.13
- GMRE $7.73
- Analyst Decision
- LXRX Buy
- GMRE Buy
- Analyst Count
- LXRX 5
- GMRE 3
- Target Price
- LXRX $3.23
- GMRE $10.38
- AVG Volume (30 Days)
- LXRX 1.8M
- GMRE 691.1K
- Earning Date
- LXRX 11-11-2025
- GMRE 11-05-2025
- Dividend Yield
- LXRX N/A
- GMRE 7.85%
- EPS Growth
- LXRX N/A
- GMRE N/A
- EPS
- LXRX N/A
- GMRE 0.07
- Revenue
- LXRX $58,432,000.00
- GMRE $141,896,000.00
- Revenue This Year
- LXRX N/A
- GMRE $7.69
- Revenue Next Year
- LXRX N/A
- GMRE $4.04
- P/E Ratio
- LXRX N/A
- GMRE $113.85
- Revenue Growth
- LXRX 1504.83
- GMRE 2.95
- 52 Week Low
- LXRX $0.28
- GMRE $6.06
- 52 Week High
- LXRX $2.18
- GMRE $10.46
- Technical
- Relative Strength Index (RSI)
- LXRX 50.83
- GMRE 66.58
- Support Level
- LXRX $1.03
- GMRE $7.26
- Resistance Level
- LXRX $1.15
- GMRE $7.73
- Average True Range (ATR)
- LXRX 0.06
- GMRE 0.15
- MACD
- LXRX -0.01
- GMRE 0.02
- Stochastic Oscillator
- LXRX 50.00
- GMRE 95.70
About LXRX Lexicon Pharmaceuticals Inc.
Lexicon Pharmaceuticals Inc is a biopharmaceutical company. It is engaged in the discovery, development, and commercialization of pharmaceutical products for the treatment of human diseases. Some of its drug candidates are LX9211, an orally-delivered small molecule drug candidate, also developing LX9851, an orally-delivered small molecule drug candidate, as a treatment for obesity and associated cardiometabolic.
About GMRE Global Medical REIT Inc.
Global Medical REIT Inc is engaged predominantly in the acquisition of purpose-built healthcare facilities and the leasing of those facilities to physician groups and regional and national healthcare systems. The company's principal business objective is to provide attractive, risk-adjusted returns to its stockholders through a combination of reliable dividends and long-term capital appreciation. Its healthcare facilities are located in secondary markets and suburbs of primary markets and are typically leased to single-tenants under triple-net leases.